Julie Rich Ingelfinger, M.D.
This page shows the publications co-authored by Julie Ingelfinger and Rafail Kushak.
Platelet thrombus formation in eHUS is prevented by anti-MBL2. PLoS One. 2019; 14(12):e0220483.
Both platelets and fibrin deposition are increased in the glomeruli of mice after treatment with Shiga toxin-2. Kidney Int. 2017 12; 92(6):1556-1557.
Shiga toxin-1 Decreases Endothelial Cell Tissue Factor Pathway Inhibitor Not Co-localized with Tissue Factor on the Cell Membrane. Thromb Res. 2015 Jun; 135(6):1214-7.
Shiga toxin downregulates tissue factor pathway inhibitor, modulating an increase in the expression of functional tissue factor on endothelium. Thromb Res. 2013 Jun; 131(6):521-8.
Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression. Pediatr Nephrol. 2008 Feb; 23(2):221-31.
Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin. Kidney Int. 2005 Jun; 67(6):2254-66.
Detached endothelial cells and microparticles as sources of tissue factor activity. Thromb Res. 2005; 116(5):409-19.
Shiga toxin enhances functional tissue factor on human glomerular endothelial cells: implications for the pathophysiology of hemolytic uremic syndrome. J Thromb Haemost. 2005 Apr; 3(4):752-62.
The connection strength for co-authors is the sum of the scores for each of their shared publications.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.